Literature DB >> 2396539

A computed tomography study on formation, propagation, and resolution of edema fluid in metastatic brain tumors.

U Ito1, H J Reulen, H Tomita, J Ikeda, J Saito, T Maehara.   

Abstract

Propagation of contrast medium, which extravasated from small metastatic brain tumor, was imaged via CT. By maintaining a constant blood level of the contrast medium by prolonged infusion of 200 ml of 60% meglumine amidtrizoate for 3 hr and thus maintaining a constant passage of contrast labeled edema fluid into the peritumoral extracellular space, the spread of the newly formed edema fluid can be imaged by repeated CTs as a gradually expanding peritumoral circular enhancement into the neighboring white matter. Four patients with small metastatic brain tumor were investigated. CT scans were taken at identical levels 1.5, 3, 6, 9, and 12 hr after start of contrast infusion. After 4 to 7 days of dexamethasone treatment (0.15-0.25 mg/kg/day), the examination was repeated. The area of the expanding circular enhancement was planimetrically measured. From these values, the increase in radius per hour, respectively, in volume per hour were calculated assuming a spherical geometry. These data enabled a determination of the formation rate of edema fluid, of the speed of edema propagation, and of the resolution rate of edema fluid during tissue passage. The formation rate of edema fluid amounted to 0.6 to 3.2 ml/hr depending on tumor diameter and was reduced by about 30% after dexamethasone treatment. Edema fluid traveled 4.8 mm during the first 180 min and 1.9 mm during the consecutive 90 min. The resolution rate of edema fluid during tissue passage amounted to 0.05 ml/hr/cm3 white matter before dexamethasone treatment.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2396539

Source DB:  PubMed          Journal:  Adv Neurol        ISSN: 0091-3952


  9 in total

1.  Convection-enhanced delivery of macromolecules in the brain.

Authors:  R H Bobo; D W Laske; A Akbasak; P F Morrison; R L Dedrick; E H Oldfield
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

2.  Continuous monitoring of the Monro-Kellie doctrine: is it possible?

Authors:  Dong-Joo Kim; Zofia Czosnyka; Magdalena Kasprowicz; Piotr Smieleweski; Oliver Baledent; Anne-Marie Guerguerian; John D Pickard; Marek Czosnyka
Journal:  J Neurotrauma       Date:  2011-11-04       Impact factor: 5.269

3.  Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor.

Authors:  J D Heiss; E Papavassiliou; M J Merrill; L Nieman; J J Knightly; S Walbridge; N A Edwards; E H Oldfield
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

4.  Quantification of dispersion of Gd-DTPA from the initial area of enhancement into the peritumoral zone of edema in brain tumors.

Authors:  Igor N Pronin; Kathleen A McManus; Andrei I Holodny; Kyung K Peck; Valeri N Kornienko
Journal:  J Neurooncol       Date:  2009-03-29       Impact factor: 4.130

5.  Peritumoral edema shown by MRI predicts poor clinical outcome in glioblastoma.

Authors:  Chen-Xing Wu; Guo-Shi Lin; Zhi-Xiong Lin; Jian-Dong Zhang; Shui-Yuan Liu; Chang-Fu Zhou
Journal:  World J Surg Oncol       Date:  2015-03-11       Impact factor: 2.754

Review 6.  Gliomas and the vascular fragility of the blood brain barrier.

Authors:  Luiz Gustavo Dubois; Loraine Campanati; Cassia Righy; Isabella D'Andrea-Meira; Tania Cristina Leite de Sampaio E Spohr; Isabel Porto-Carreiro; Claudia Maria Pereira; Joana Balça-Silva; Suzana Assad Kahn; Marcos F DosSantos; Marcela de Almeida Rabello Oliveira; Adriana Ximenes-da-Silva; Maria Celeste Lopes; Eduardo Faveret; Emerson Leandro Gasparetto; Vivaldo Moura-Neto
Journal:  Front Cell Neurosci       Date:  2014-12-12       Impact factor: 5.505

7.  Efficiency of Dexamethasone for Treatment of Vasogenic Edema in Brain Metastasis Patients: A Radiographic Approach.

Authors:  Tanja Schroeder; Paul Bittrich; Clara Noebel; Jan Felix Kuhne; Julian Schroeder; Gerhard Schoen; Jens Fiehler; Helge C Kniep; Susanne Gellißen
Journal:  Front Oncol       Date:  2019-07-30       Impact factor: 6.244

Review 8.  Pro- and Antiangiogenic Factors in Gliomas: Implications for Novel Therapeutic Possibilities.

Authors:  Magdalena Groblewska; Barbara Mroczko
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

9.  Treatment with the NK1 antagonist emend reduces blood brain barrier dysfunction and edema formation in an experimental model of brain tumors.

Authors:  Elizabeth Harford-Wright; Kate M Lewis; Mounir N Ghabriel; Robert Vink
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.